Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

POLIOVIRUS VACCINE LIVE ORAL TRIVALENT DIN 00075043

Status: Cancelled Post Market
Holder: AVENTIS PASTEUR LIMITED
Molecule: POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1

Health Canada record

Active ingredient(s)POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1 1000000 UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2 100000 UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3 300000 UNIT
Dosage formSuspension
RouteOral
ScheduleSCHEDULE D
ClassHuman
ATCJ07BF02 POLIOMYELITIS ORAL, TRIVALENT, LIVE ATTENUATED
Original market date31-Dec-1961
Current status date06-Apr-2000
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1

DINProductCompanyFormStrengthStatus
00752622POLIOVIRUS VACCINE LIVE ORAL TRIVALENT HUMANAVENTIS PASTEUR LIMITEDSolutionPOLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1 1000000 UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2 100000 UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3 150000 UNITCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
52231995-03-30Supplement to a New Drug Submission (SNDS)CHANGE IN MANUFACTURING
Request a quote for POLIOVIRUS VACCINE LIVE ORAL TRIVALENT

How to read a Canadian DIN record